The global Afutuzumab market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possibly more direct cytotoxicity than previously available type I antibodies such as rituximab and ofatumumab which have more complement-dependent cytotoxicity.
This report is a detailed and comprehensive analysis for global Afutuzumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Afutuzumab market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Afutuzumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Afutuzumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Afutuzumab market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Afutuzumab
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Afutuzumab market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical, Jiangxi Ruiweier Biotechnology, Qingdao Jieshikang Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Afutuzumab market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Patent
Generic
Market segment by Application
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Major players covered
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Afutuzumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Afutuzumab, with price, sales quantity, revenue, and global market share of Afutuzumab from 2020 to 2025.
Chapter 3, the Afutuzumab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afutuzumab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Afutuzumab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Afutuzumab.
Chapter 14 and 15, to describe Afutuzumab sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Afutuzumab Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Patent
1.3.3 Generic
1.4 Market Analysis by Application
1.4.1 Overview: Global Afutuzumab Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Chronic Lymphocytic Leukemia
1.4.3 Follicular Lymphoma
1.5 Global Afutuzumab Market Size & Forecast
1.5.1 Global Afutuzumab Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Afutuzumab Sales Quantity (2020-2031)
1.5.3 Global Afutuzumab Average Price (2020-2031)
2 Manufacturers Profiles
2.1 BOC Sciences
2.1.1 BOC Sciences Details
2.1.2 BOC Sciences Major Business
2.1.3 BOC Sciences Afutuzumab Product and Services
2.1.4 BOC Sciences Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 BOC Sciences Recent Developments/Updates
2.2 Carbosynth
2.2.1 Carbosynth Details
2.2.2 Carbosynth Major Business
2.2.3 Carbosynth Afutuzumab Product and Services
2.2.4 Carbosynth Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Carbosynth Recent Developments/Updates
2.3 Roche Group
2.3.1 Roche Group Details
2.3.2 Roche Group Major Business
2.3.3 Roche Group Afutuzumab Product and Services
2.3.4 Roche Group Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Roche Group Recent Developments/Updates
2.4 TargetMol Chemicals
2.4.1 TargetMol Chemicals Details
2.4.2 TargetMol Chemicals Major Business
2.4.3 TargetMol Chemicals Afutuzumab Product and Services
2.4.4 TargetMol Chemicals Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 TargetMol Chemicals Recent Developments/Updates
2.5 Wonda Science
2.5.1 Wonda Science Details
2.5.2 Wonda Science Major Business
2.5.3 Wonda Science Afutuzumab Product and Services
2.5.4 Wonda Science Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Wonda Science Recent Developments/Updates
2.6 Absin Bioscience
2.6.1 Absin Bioscience Details
2.6.2 Absin Bioscience Major Business
2.6.3 Absin Bioscience Afutuzumab Product and Services
2.6.4 Absin Bioscience Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Absin Bioscience Recent Developments/Updates
2.7 Chunchuang (Wuhan) Technology
2.7.1 Chunchuang (Wuhan) Technology Details
2.7.2 Chunchuang (Wuhan) Technology Major Business
2.7.3 Chunchuang (Wuhan) Technology Afutuzumab Product and Services
2.7.4 Chunchuang (Wuhan) Technology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Chunchuang (Wuhan) Technology Recent Developments/Updates
2.8 Hubei Kele Fine Chemical
2.8.1 Hubei Kele Fine Chemical Details
2.8.2 Hubei Kele Fine Chemical Major Business
2.8.3 Hubei Kele Fine Chemical Afutuzumab Product and Services
2.8.4 Hubei Kele Fine Chemical Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
2.9 Jiangxi Ruiweier Biotechnology
2.9.1 Jiangxi Ruiweier Biotechnology Details
2.9.2 Jiangxi Ruiweier Biotechnology Major Business
2.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Product and Services
2.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Jiangxi Ruiweier Biotechnology Recent Developments/Updates
2.10 Qingdao Jieshikang Biotechnology
2.10.1 Qingdao Jieshikang Biotechnology Details
2.10.2 Qingdao Jieshikang Biotechnology Major Business
2.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Product and Services
2.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Qingdao Jieshikang Biotechnology Recent Developments/Updates
2.11 Shanghai Biochempartner
2.11.1 Shanghai Biochempartner Details
2.11.2 Shanghai Biochempartner Major Business
2.11.3 Shanghai Biochempartner Afutuzumab Product and Services
2.11.4 Shanghai Biochempartner Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Shanghai Biochempartner Recent Developments/Updates
2.12 Shanghai Macklin Biochemical
2.12.1 Shanghai Macklin Biochemical Details
2.12.2 Shanghai Macklin Biochemical Major Business
2.12.3 Shanghai Macklin Biochemical Afutuzumab Product and Services
2.12.4 Shanghai Macklin Biochemical Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shanghai Macklin Biochemical Recent Developments/Updates
2.13 Shanghai Qiming Biotechnology
2.13.1 Shanghai Qiming Biotechnology Details
2.13.2 Shanghai Qiming Biotechnology Major Business
2.13.3 Shanghai Qiming Biotechnology Afutuzumab Product and Services
2.13.4 Shanghai Qiming Biotechnology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shanghai Qiming Biotechnology Recent Developments/Updates
2.14 Shanghai Saimai Biotechnology
2.14.1 Shanghai Saimai Biotechnology Details
2.14.2 Shanghai Saimai Biotechnology Major Business
2.14.3 Shanghai Saimai Biotechnology Afutuzumab Product and Services
2.14.4 Shanghai Saimai Biotechnology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Shanghai Saimai Biotechnology Recent Developments/Updates
2.15 Shanghai Shize Biological Technology
2.15.1 Shanghai Shize Biological Technology Details
2.15.2 Shanghai Shize Biological Technology Major Business
2.15.3 Shanghai Shize Biological Technology Afutuzumab Product and Services
2.15.4 Shanghai Shize Biological Technology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Shanghai Shize Biological Technology Recent Developments/Updates
2.16 Shanghai Yifei Biotechnology
2.16.1 Shanghai Yifei Biotechnology Details
2.16.2 Shanghai Yifei Biotechnology Major Business
2.16.3 Shanghai Yifei Biotechnology Afutuzumab Product and Services
2.16.4 Shanghai Yifei Biotechnology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Shanghai Yifei Biotechnology Recent Developments/Updates
2.17 Shanghai Yu'ang Chemical
2.17.1 Shanghai Yu'ang Chemical Details
2.17.2 Shanghai Yu'ang Chemical Major Business
2.17.3 Shanghai Yu'ang Chemical Afutuzumab Product and Services
2.17.4 Shanghai Yu'ang Chemical Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Shanghai Yu'ang Chemical Recent Developments/Updates
2.18 Tianmen Hengchang Chemical
2.18.1 Tianmen Hengchang Chemical Details
2.18.2 Tianmen Hengchang Chemical Major Business
2.18.3 Tianmen Hengchang Chemical Afutuzumab Product and Services
2.18.4 Tianmen Hengchang Chemical Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Tianmen Hengchang Chemical Recent Developments/Updates
2.19 Wuhan Sunrise Technology Development
2.19.1 Wuhan Sunrise Technology Development Details
2.19.2 Wuhan Sunrise Technology Development Major Business
2.19.3 Wuhan Sunrise Technology Development Afutuzumab Product and Services
2.19.4 Wuhan Sunrise Technology Development Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Wuhan Sunrise Technology Development Recent Developments/Updates
2.20 Wuhan Yingnuo Pharmaceutical Technology
2.20.1 Wuhan Yingnuo Pharmaceutical Technology Details
2.20.2 Wuhan Yingnuo Pharmaceutical Technology Major Business
2.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product and Services
2.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
3 Competitive Environment: Afutuzumab by Manufacturer
3.1 Global Afutuzumab Sales Quantity by Manufacturer (2020-2025)
3.2 Global Afutuzumab Revenue by Manufacturer (2020-2025)
3.3 Global Afutuzumab Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Afutuzumab by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Afutuzumab Manufacturer Market Share in 2024
3.4.3 Top 6 Afutuzumab Manufacturer Market Share in 2024
3.5 Afutuzumab Market: Overall Company Footprint Analysis
3.5.1 Afutuzumab Market: Region Footprint
3.5.2 Afutuzumab Market: Company Product Type Footprint
3.5.3 Afutuzumab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Afutuzumab Market Size by Region
4.1.1 Global Afutuzumab Sales Quantity by Region (2020-2031)
4.1.2 Global Afutuzumab Consumption Value by Region (2020-2031)
4.1.3 Global Afutuzumab Average Price by Region (2020-2031)
4.2 North America Afutuzumab Consumption Value (2020-2031)
4.3 Europe Afutuzumab Consumption Value (2020-2031)
4.4 Asia-Pacific Afutuzumab Consumption Value (2020-2031)
4.5 South America Afutuzumab Consumption Value (2020-2031)
4.6 Middle East & Africa Afutuzumab Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Afutuzumab Sales Quantity by Type (2020-2031)
5.2 Global Afutuzumab Consumption Value by Type (2020-2031)
5.3 Global Afutuzumab Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Afutuzumab Sales Quantity by Application (2020-2031)
6.2 Global Afutuzumab Consumption Value by Application (2020-2031)
6.3 Global Afutuzumab Average Price by Application (2020-2031)
7 North America
7.1 North America Afutuzumab Sales Quantity by Type (2020-2031)
7.2 North America Afutuzumab Sales Quantity by Application (2020-2031)
7.3 North America Afutuzumab Market Size by Country
7.3.1 North America Afutuzumab Sales Quantity by Country (2020-2031)
7.3.2 North America Afutuzumab Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Afutuzumab Sales Quantity by Type (2020-2031)
8.2 Europe Afutuzumab Sales Quantity by Application (2020-2031)
8.3 Europe Afutuzumab Market Size by Country
8.3.1 Europe Afutuzumab Sales Quantity by Country (2020-2031)
8.3.2 Europe Afutuzumab Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Afutuzumab Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Afutuzumab Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Afutuzumab Market Size by Region
9.3.1 Asia-Pacific Afutuzumab Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Afutuzumab Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Afutuzumab Sales Quantity by Type (2020-2031)
10.2 South America Afutuzumab Sales Quantity by Application (2020-2031)
10.3 South America Afutuzumab Market Size by Country
10.3.1 South America Afutuzumab Sales Quantity by Country (2020-2031)
10.3.2 South America Afutuzumab Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Afutuzumab Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Afutuzumab Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Afutuzumab Market Size by Country
11.3.1 Middle East & Africa Afutuzumab Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Afutuzumab Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Afutuzumab Market Drivers
12.2 Afutuzumab Market Restraints
12.3 Afutuzumab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Afutuzumab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Afutuzumab
13.3 Afutuzumab Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Afutuzumab Typical Distributors
14.3 Afutuzumab Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology
听
听
*If Applicable.
